Insider · CIK 0001959565
Phillip E Lee
Files at VXRT (Vaxart, Inc.). First filing -, latest -.
In brief
Phillip E Lee files SEC Form 4 as CFO at VXRT (Vaxart, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Phillip E Lee has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 27, 2025 | VXRT Vaxart, Inc. | 81,364 0.04% of outstanding | $37k | May 27, 2025 | none |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 15, 2024 | VXRT Vaxart, Inc. | FTax withholding Common Stock | -6,132 | $0.59 | $3,630 | 233,669 | Dec 17, 2024 |
Questions about Phillip E Lee
Answered from the filings on this page, as of the latest one.
Is Phillip E Lee buying or selling?
Phillip E Lee has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Phillip E Lee's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Phillip E Lee has 0.
Where does Phillip E Lee file Form 4?
Phillip E Lee has filed Form 4 at VXRT (Vaxart, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.